Porter DL - Search Results

1

Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.

Yam C, Landsburg DJ, Nead KT, Lin X, Mato AR, Svoboda J, Loren AW, Frey NV, Stadtmauer EA, Porter DL, Schuster SJ, Nasta SD. Yam C, et al. Among authors: porter dl. Am J Hematol. 2016 Jul;91(7):672-6. doi: 10.1002/ajh.24372. Epub 2016 Apr 24. Am J Hematol. 2016. PMID: 27012928 Free article.

2

Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.

Tsai DE, Nearey M, Hardy CL, Tomaszewski JE, Kotloff RM, Grossman RA, Olthoff KM, Stadtmauer EA, Porter DL, Schuster SJ, Luger SM, Hodinka RL. Tsai DE, et al. Among authors: porter dl. Am J Transplant. 2002 Nov;2(10):946-54. doi: 10.1034/j.1600-6143.2002.21011.x. Am J Transplant. 2002. PMID: 12482147 Free article.

3

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.

Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Laport GG, et al. Among authors: porter dl. Blood. 2003 Sep 15;102(6):2004-13. doi: 10.1182/blood-2003-01-0095. Epub 2003 May 22. Blood. 2003. PMID: 12763934 Free article. Clinical Trial.

4

Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.

Gerecitano J, Mathias C, Mick R, Duffy KM, Luger S, Stadtmauer EA, Schuster SJ, Tsai D, Nasta S, Berlin J, Phillips DK, High KA, Porter DL. Gerecitano J, et al. Among authors: porter dl. J Hematother Stem Cell Res. 2003 Apr;12(2):215-23. doi: 10.1089/152581603321628359. J Hematother Stem Cell Res. 2003. PMID: 12804180

5

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

Tsai DE, Maillard I, Schuster SJ, Nasta SD, Porter DL, Klumpp TR, Goldenberg DM, Luger SM, Alavi A, Sharkey RM, Hartzell KB, Stadtmauer EA. Tsai DE, et al. Among authors: porter dl. Clin Lymphoma. 2003 Jun;4(1):56-9. doi: 10.3816/clm.2003.n.015. Clin Lymphoma. 2003. PMID: 12837157

6

Leukemic gingival infiltrate as an indicator of chemotherapeutic failure following monoclonal antibody therapy: a case report.

Sollecito TP, Draznin J, Parisi E, Duffy K, Stadtmauer EA, Luger SM, Schuster SJ, Tsai D, Porter DL. Sollecito TP, et al. Among authors: porter dl. Spec Care Dentist. 2003;23(3):108-10. doi: 10.1111/j.1754-4505.2003.tb01670.x. Spec Care Dentist. 2003. PMID: 14650559

7

Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications?

Kaufman LJ, Clark TW, Roberts DA, Freiman DB, Shlansky-Goldberg RD, Patel AA, Mondschein JI, Stavropoulos SW, Soulen MC, Solomon JA, Tuite CM, Cope C, Porter DL, Stadtmauer EA, Cunningham KA, Trerotola SO. Kaufman LJ, et al. Among authors: porter dl. J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):57-61. doi: 10.1097/01.rvi.0000106383.63463.6b. J Vasc Interv Radiol. 2004. PMID: 14709689

8

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.

Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, Porter DL, Elstrom R, Tsai DE. Vogl DT, et al. Among authors: porter dl. Leuk Lymphoma. 2005 Sep;46(9):1313-20. doi: 10.1080/10428190500158649. Leuk Lymphoma. 2005. PMID: 16109609

9

Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.

Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, Bloom RD, Brozena SC, Hodinka RL, Stadtmauer EA, Schuster SJ, Nasta SD, Porter DL, Luger SM, Klumpp TR. Tsai DE, et al. Among authors: porter dl. Clin Transplant. 2005 Oct;19(5):644-52. doi: 10.1111/j.1399-0012.2005.00388.x. Clin Transplant. 2005. PMID: 16146557

10

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

Porter DL, Levine BL, Bunin N, Stadtmauer EA, Luger SM, Goldstein S, Loren A, Phillips J, Nasta S, Perl A, Schuster S, Tsai D, Sohal A, Veloso E, Emerson S, June CH. Porter DL, et al. Blood. 2006 Feb 15;107(4):1325-31. doi: 10.1182/blood-2005-08-3373. Epub 2005 Nov 3. Blood. 2006. PMID: 16269610 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters